• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Peeled/Delaminated (1454)
Patient Problem Vascular Dissection (3160)
Event Date 02/23/2022
Event Type  malfunction  
Manufacturer Narrative
The item number and lot number of the device could not be provided, so no manufacturing evaluation could not be performed.The device remains implanted.As no identity or sufficient images of the device were provided for evaluation, the reported issue of this literature could not be confirmed.Citation: xi zhang, bo hu, yong xu, qiquan lai, et al.1 ¿6 © the author(s) 2022 article reuse guidelines: sagepub.Com/journals-permissions doi: 10.1177/11297298221074455journals.Sagepub.Com/home/jva cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was received through literature ¿delamination and dissection of arteriovenous grafts: a multicenter report of four cases¿ published by the journal of vascular access 1¿6.The study was to report four cases of av graft dysfunction and failure rarely caused by graft delamination and dissection.Acuseal graft (6mm, w.L.Gore & associates, flagstaff, az, usa) was implanted.Graft delamination and dissection should be considered as a possible cause for av graft dysfunction and failure.Stenting and graft replacement may be recommended to treat av graft dissection and delamination.Case report 1: a (b)(6) female with end-stage renal disease had been on hemodialysis using a radial-cephalic fistula in the right arm and a brachial-cephalic fistula in the left arm for 3.5years.Eight months ago, a brachial-cephalic loop acuseal graft (6mm, w.L.Gore & associates, flagstaff, az, usa) was implanted in the left forearm below the elbow joint.The av graft was never punctured or canalized for hemodialysis.The patient was not on anti-platelet or anti-coagulation medications.At 1-month postoperative visit, ultrasound examination detected delamination and dissection in the graft segment below the elbow joint located 5cm away from the venous anastomosis (figure 1(a)).The delamination resulted in a luminal narrowing with the luminal diameter of 1.7mm and a filling defect shown in color doppler ultrasonography (figure 1(b)).The delamination and dissection were untreated and left for regular follow-up surveillance.Five months later, the av graft delamination and dissection disappeared (figure 1(c)) and the graft blood flow restored spontaneously (figure 1(d)).
 
Manufacturer Narrative
Update c1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13838683
MDR Text Key293178344
Report Number2017233-2022-02815
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/24/2022
Initial Date FDA Received03/21/2022
Supplement Dates Manufacturer Received02/24/2022
Supplement Dates FDA Received05/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient SexFemale
-
-